Decisions About Cancer Screening in Alzheimer's Disease
Completed · Not applicable
Conditions studied: Cancer, Breast, Alzheimer Disease
In brief
The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study tests if an evidence-based decision aid for dementia caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled trial will recruit up to 450 dyads (900 individual participants) of older women with dementia and a family caregiver, for a goal of 426 dyad baselines (852 individual participants).
Key facts
- Study ID
- NCT03282097
- Run by
- Indiana University
- People needed
- 442
- Starts
- 2017-12-01
- Expected to finish
- 2024-07-01
- Last updated by the study team
- 2025-08-11
Who can join
Age: 75 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Parkview Health — Fort Wayne, Indiana, United States
- Alzheimer's Association — Indianapolis, Indiana, United States
- Eskenazi Health — Indianapolis, Indiana, United States
- IU Health — Indianapolis, Indiana, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.